Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2. - Wikidata - awgldk - TriplyDB

Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2.

Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2.

http://www.wikidata.org/entity/Q33748408

about

Peripheral blood mononuclear cell proteome changes in patients with myelodysplastic syndrome Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression.Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups.Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis.Mass spectrometry in leukemia research and treatment.New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis.Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes.

P2860

Q35556586-345A966E-9999-4240-99DA-433595536FE2 Q35778619-00E88355-5D79-4C83-AB8B-7045D8E9DFA7 Q36095679-73C10292-1448-485E-A7ED-9D38E01079E5 Q36247995-98B1AAAE-67F8-4424-986B-994F35ED4337 Q38365432-23B3000C-1A3E-4BEE-884E-02EC39DE7CF2 Q38986294-92EDCDA3-922A-4C03-9F2D-6E5AC7C2C1F3 Q50225588-A6D0E8AA-4439-459C-962A-F246557313A0

P2860

Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2.

http://www.wikidata.org/entity/Q33748408

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Proteome changes in the plasma ...... with excess blasts subtype 2.

@ast

Proteome changes in the plasma ...... with excess blasts subtype 2.

@en

type

label

Proteome changes in the plasma ...... with excess blasts subtype 2.

@ast

Proteome changes in the plasma ...... with excess blasts subtype 2.

@en

prefLabel

Proteome changes in the plasma ...... with excess blasts subtype 2.

@ast

Proteome changes in the plasma ...... with excess blasts subtype 2.

@en

P1433

Q33748408-BF788406-232C-4301-8839-FEB578D1B1C0

P1476

Q33748408-6AA7959C-9EAF-4FAB-B40A-2AA11A19188E

P2093

Q33748408-2B6AD53A-41D4-40C5-BA05-01ED239EFFB6

Q33748408-6D3ECF80-4741-461A-AD04-F8AAB4D03330

Q33748408-917C994E-BA58-4083-BE63-DD8D68335B2B

Q33748408-9AC71B54-53FD-43D1-A288-3E70E0672A48

P2860

Q33748408-0FB08E7B-2E2C-45C8-A925-65FFBDF4D105

Q33748408-15E71034-3562-4373-AC02-82C0223FFF37

Q33748408-164AE3A6-583F-44DC-90A8-56E10B5D136A

Q33748408-2A321F91-05A4-4830-9D9E-7F94B3BC7C70

Q33748408-2DD5CCEC-2DBF-46DF-BC7B-D54706EAF1E1

Q33748408-31C3D3FB-AD81-4FEF-8056-EDE375810A80

Q33748408-326831F9-C633-4C28-842D-49F67E3871FF

Q33748408-4C364CE8-5B42-4B02-A1AE-544188BDAC4E

Q33748408-5116386B-6510-4F28-A3B8-41BFE20AE752

Q33748408-54496B8A-DEB2-4B38-A1A3-0A99807B0F02

P304

Q33748408-144DF395-B137-4165-8113-9C76665E842B

P31

Q33748408-64A334BD-8DEE-40AD-B212-1CC13D82B4F9

P356

Q33748408-9D1B7C47-8E17-452A-A114-8B62E9BE6172

P478

Q33748408-17164422-4064-4F37-8386-BC38794D95BE

P50

Q33748408-120BF7FD-8561-4C8C-B9C7-C9B1008B44DD

Q33748408-22DF9A40-90E4-4927-A2BD-98A1DD30826B

P577

Q33748408-172CCD22-ED85-48FB-A585-ABB598C538E8

P5875

Q33748408-79D8834E-3E79-4E1B-A31D-C1917B6953E7

P698

Q33748408-4503DD56-5F6B-4FFF-BB27-E181549C0AA5

P932

Q33748408-4C107BEE-C64B-48AA-81A0-D0ECC562C8BC

P356

P1433

Disease Markers

P1476

Proteome changes in the plasma ...... a with excess blasts subtype 2

@en

P2093

Jan E Dyr

http://www.w3.org/2001/XMLSchema#string

Jaroslav Cermak

http://www.w3.org/2001/XMLSchema#string

Klara Pecankova

http://www.w3.org/2001/XMLSchema#string

Zuzana Riedelova-Reicheltova

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Image to ImageJ: 25 years of image analysis

Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation

Biosensors in clinical practice: focus on oncohematology.

The World Health Organization (WHO) classification of the myeloid neoplasms

LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.

Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma.

Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome.

Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin

Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia

P304

178709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/178709

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263396403

http://www.w3.org/2001/XMLSchema#string

P698

24958999

http://www.w3.org/2001/XMLSchema#string

P932

4055597

http://www.w3.org/2001/XMLSchema#string